Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.

Miehlke S, Lucendo AJ, Straumann A, Jan Bredenoord A, Attwood S

Open source

DOI
10.1177/1756284820927282
Published
2020
Container
Therapeutic advances in gastroenterology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/1756284820927282,
  title = {Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.},
  author = {Miehlke S and Lucendo AJ and Straumann A and Jan Bredenoord A and Attwood S},
  year = {2020},
  journal = {Therapeutic advances in gastroenterology},
  doi = {10.1177/1756284820927282},
  url = {https://doi.org/10.1177/1756284820927282}
}

RIS

TY  - JOUR
TI  - Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.
AU  - Miehlke S
AU  - Lucendo AJ
AU  - Straumann A
AU  - Jan Bredenoord A
AU  - Attwood S
PY  - 2020
JO  - Therapeutic advances in gastroenterology
DO  - 10.1177/1756284820927282
UR  - https://doi.org/10.1177/1756284820927282
ER  - 

APA

S, M., AJ, L., A, S., A, J. B., & S, A. (2020). Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence.. Therapeutic advances in gastroenterology. https://doi.org/10.1177/1756284820927282

Source records